TCTR20170206007招募中4 期
The Study of Efficacy and Safety of Sebclair® in Mild to Moderate Degree Seborrheic Dermatitis (SD)
A. Menarini (Thailand) Ltd.0 个研究点目标入组 30 人开始时间: 2017年2月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •18-60 years with mild to moderate seborrheic dermatitis
排除标准
- •those with underlying medical problems or with current medications taken.
- •those who stop using topical medications not less than two weeks or systemic medications not less then 4 weeks
- •Pregnancy or lactating status
研究者
相似试验
已完成
不适用
Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancercolorectal cancerJPRN-UMIN000001547Tsukuba Cancer Clinical Trial Group400
尚未招募
4 期
This study aims to compare 2 facial plane blocks using local anesthestic drug in providing pain free period in patients undergoing abdominal surgeries under general anesthesiaCTRI/2024/06/069573Dr Priyanka D S
尚未招募
不适用
A prospective study about efficacy and safety of selective arterial injection chemotherapy for ineffective or intorelable to the standard chemotherapy in advanced esophageal cancerEsophagusJPRN-UMIN000028542Showa University Koto Toyosu Hospital50
招募中
1 期
Placenta extract in the treatment of androgenetic hair lossIRCT20210612051545N5Tehran University of Medical Sciences30
招募中
1 期
Placenta growth factors in the treatment of androgenetic alopeciaAndrogenic alopecia.Androgenic alopeciaIRCT20210612051545N4Tehran University of Medical Sciences30